November 24th 2024
Patients experienced similar safety and efficacy if they received first-line or later-line treatment for unresectable hepatocellular carcinoma (u-HCC).
Study Finds Significant Glaucoma Surgery, Mortality Risk Link in Elderly Patients
August 25th 2021Elderly patients who underwent surgery for glaucoma had a greater risk of all-cause and cause-specific mortality than those who did not have surgery, including greater risk of cancer and neurologic cause–related mortality.
Read More
Improved Immunotherapy Education Needed for Patients to Grasp Benefits, Risks
August 25th 2021Survey responses from patients with advanced cancer revealed that there were gaps in knowledge across various aspects of immunotherapy treatment, including about side effects and curative potential.
Read More
Patients with comorbid Alzheimer disease and insomnia were found to be more likely to report claims of higher cost health care services such as inpatient hospitalization and emergency care, along with significantly greater mean total annual health care costs than those without insomnia.
Read More
Study Finds Home-Based Postoperative Management of Deep Brain Stimulation Safe, Effective
August 23rd 2021Postoperative management of deep brain stimulation in patients with Parkinson disease was shown to be safe and effective when administered at home, which may reduce necessity of in-clinic visits and care access issues.
Read More
Improving COPD Care With Remote Patient Monitoring
August 21st 2021Worsening chronic obstructive pulmonary disease (COPD) symptoms are often underreported by patients who cannot recognize these changes as sign of decline, but they can be objectively measured through remote patient monitoring (RPM).
Read More
Aflibercept Likely to Improve Severity, Complications of Nonproliferative Diabetic Retinopathy
August 21st 2021Findings of the PANORAMA randomized clinical trial show that when patients with severe nonproliferative diabetic retinopathy were treated with intravitreal aflibercept, severity improved over 100 weeks and the likelihood of vision-threatening complications significantly reduced.
Read More
Low Safety Risk Observed in Office-Based, Operating Room Anti-VEGF Intravitreal Injections
August 19th 2021A low risk of adverse safety outcomes was observed in anti–vascular endothelial growth factor (VEGF) intravitreal injections performed in office-based and operating room settings, with a higher rate of culture-positive endophthalmitis found in the office setting.
Read More
Health Officials Lay Out Plan for US COVID-19 Booster Shots in General Public
August 18th 2021Top US health officials outlined plans for rolling out COVID-19 booster shots to all American adults beginning in September, while CMS announced that nursing homes will be required to implement mandatory vaccinations for staff.
Read More
AHA Releases Scientific Statement on OSA, Cardiovascular Disease Link in Children and Adolescents
August 18th 2021The scientific statement addresses current knowledge regarding the impact of obstructive sleep apnea on the cardiovascular health of children and adolescents, as well as best practices to evaluate symptoms.
Read More
Addressing Pay-for-Delay Deals, Anticompetition in the Pharmaceutical Industry
August 17th 2021Despite executive orders by the Biden administration aimed to improve competition in the pharmaceutical industry, pay-for-delay deals and other antitrust issues continue to be reported. On this episode of Managed Care Cast, we speak on the history and prevalence of these anticompetitive tactics and steps to limit these deals.
Listen
US health experts to recommend coronavirus vaccine booster shots for all Americans 8 months after receiving their second dose; 5 states report record 7-day averages of new daily cases of COVID-19; debunking concerns of people receiving blood transfusions from vaccinated individuals.
Read More
Clinical Decision Support Tool Raises Flu Vaccination Rates in Hospitalized Children
August 16th 2021A recent study found half of hospitalized children received a flu vaccination when their providers used a clinical decision support tool; however, that is still lower than the 63% national average for all children.
Read More
Service Line Care Delivery Model for COVID-19 Patient-Centric Care
The authors provide steps hospitals can take to align their care delivery model to effectively meet the demands of a public health crisis such as the current pandemic.
Read More
Dr Rajesh Rajpal Discusses Screen Usage, Eye Issues Amid the Pandemic
August 13th 2021Rajesh Rajpal, MD, chief medical officer, global head of clinical medical affairs, Johnson & Johnson Vision, speaks on the impact of screen usage for eyes and trends in eye symptom burden reported amid the pandemic.
Watch
High-Dose Methotrexate Effective in Preventing Isolated CNS Relapse in Diffuse Large B-Cell Lymphoma
August 13th 2021Risk of isolated central nervous system (CNS) involvement was found to be significantly lower in patients with diffuse large B-cell lymphoma who received high-dose methotrexate vs RCHOP chemotherapy, although risk of concomitant CNS-systemic relapse rates were similar between both groups.
Read More
CDC Advisory Committee Endorses Booster Shot for Immunocompromised
August 13th 2021The meeting comes a day after the FDA approved a third dose of a COVID-19 vaccine from Pfizer-BioNTech and Moderna in people who have received organ transplants or have other conditions that have damaged their immune systems.
Read More
After 3 Months of Decline, Telehealth Utilization Stabilizes in May 2021
August 12th 2021Telehealth utilization stabilized in May 2021 after a 3-month drop, according to FAIR Health’s Monthly Telehealth Regional Tracker. Robin Gelburd, JD, president of FAIR Health, discusses the stabilization of telehealth utilization in May 2021 after a 3-month drop.
Read More
Study Explores Why People Refuse to Hear About Secondary Genetic Findings
August 11th 2021Fear of negative emotions, lack of interest, and distrust of medical institutions were some of the reasons that participants refused to receive information regarding medically actionable secondary genetic findings, even after they received additional education on what the findings would include.
Read More
Exploring 2022 Trends in Health and Hospital Drug Spending With Vizient
August 10th 2021Vizient recently released its Summer 2021 Pharmacy Market Outlook, which projects pharmaceutical spending for 2022 based on an analysis of its members' data. On this episode of Managed Care Cast, we talk about some of the findings.
Listen
Anthony Fauci, MD, addresses potential vaccine mandates once COVID-19 vaccines gain full approval; the FDA issues finalized guidance on using a metastasis-free survival end point in clinical trials of patients with prostate cancer; spotlighting the threat of variant spread and mutation amid case surges nationwide.
Read More